Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Impact of Telemedicine in Insulin-dependent Diabetic Patients Through the ETAPES Program.

NCT04883372 is registered in ClinicalTrials.gov with Centre Hospitalier Sud Francilien as lead sponsor.

NCT NCT04883372
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04883372 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Impact of Telemedicine in Insulin-dependent Diabetic Patients Through the ETAPES Program.
Lead sponsor
Centre Hospitalier Sud Francilien
Phase
Observational
Overall status
Completed
Start date
May 22, 2021
Completion date
June 8, 2021
Enrollment
64 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes